Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia
- PMID: 24212815
- PMCID: PMC3757423
- DOI: 10.3390/cancers3022382
Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia
Abstract
There has been no systematic appraisal of ethnicity-based variations in breast cancer (BC) biology amongst women from developing countries. A qualitative systematic review was conducted of breast cancer size, stage, grade, histological type, extra-mammary involvement, hormone receptor status as well as patient demographics. This review includes patients from Africa, the Middle East, Eastern Europe, Mexico, the Caribbean and South America. BC in these regions present at an earlier age with large aggressive tumours. Distant metastases are frequently present at the time of diagnosis. African women have a higher frequency of triple negative tumours. Over half of Middle Eastern women have lymph node involvement at the time of diagnosis. Despite experiencing a lower incidence compared to the Ashkenazi Jewish population, Palestinian women have poorer five-year survival outcomes. The majority of women from Mexico and South America have stage two or three disease whilst over sixty percent of women from Eastern Europe have either stage one or stage two disease. The biological characteristics of BC in the Caribbean cannot be fully assessed due to a paucity of data from the region. BC amongst the developing world is characterised by an early peak age of onset with aggressive biological characteristics. Strategies that improve breast cancer awareness, address amenable risk factors and improve early detection are essential.
Similar articles
-
Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, eastern europe, Mexico, the Caribbean and South america.Cancers (Basel). 2011 May 13;3(2):2358-81. doi: 10.3390/cancers3022358. Cancers (Basel). 2011. PMID: 24212814 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Reproductive rights: an international sample.Conscience. 1984 May-Jun;5(3):13-4. Conscience. 1984. PMID: 12178930
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Intercontinental Comparison of Immunohistochemical Subtypes Among Individuals With Breast Cancer in South-East Asia and South America: A Scoping Systematic Review and Meta-Analysis of Observational Studies.World J Oncol. 2024 Jun;15(3):355-371. doi: 10.14740/wjon1788. Epub 2024 May 7. World J Oncol. 2024. PMID: 38751698 Free PMC article. Review.
Cited by
-
Biogenic Selenium Nanoparticles and Their Anticancer Effects Pertaining to Probiotic Bacteria-A Review.Antioxidants (Basel). 2022 Sep 27;11(10):1916. doi: 10.3390/antiox11101916. Antioxidants (Basel). 2022. PMID: 36290639 Free PMC article. Review.
-
Net survival differences of breast cancer between stages at diagnosis and age groups in the east coast region of West Malaysia: a retrospective cohort study.BMJ Open. 2021 May 18;11(5):e043642. doi: 10.1136/bmjopen-2020-043642. BMJ Open. 2021. PMID: 34006546 Free PMC article.
-
Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).BMC Cancer. 2020 Aug 10;20(1):747. doi: 10.1186/s12885-020-07250-0. BMC Cancer. 2020. PMID: 32778078 Free PMC article.
-
The Hypoxic Response Expression as a Survival Biomarkers in Treatment-Naive Advanced Breast Cancer.Asian Pac J Cancer Prev. 2020 Mar 1;21(3):629-637. doi: 10.31557/APJCP.2020.21.3.629. Asian Pac J Cancer Prev. 2020. PMID: 32212787 Free PMC article.
-
The influence of an IL-4 variable number tandem repeat (VNTR) polymorphism on breast cancer susceptibility.Pharmgenomics Pers Med. 2019 Aug 26;12:201-207. doi: 10.2147/PGPM.S220571. eCollection 2019. Pharmgenomics Pers Med. 2019. PMID: 31692576 Free PMC article.
References
-
- Bhurgri Y., Kayani N., Faridi N., Pervez S., Usman A., Bhurgri H., Malik J., Bashir I., Bhurgri A., Hasan S.H., Zaidi S.H. Patho-epidemiology of breast cancer in Karachi ‘1995-1997’. Asian Pac. J. Cancer Prev. 2007;8:215–220. - PubMed
-
- Azizsun-Nisa. Bhurgri Y., Raza F., Kayani N. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Asian Pac. J. Cancer Prev. 2008;9:553–556. - PubMed
-
- Usmani K., Khanum A., Afzal H., Ahmad N. Breast carcinoma in Pakistani women. J. Environ. Pathol. Toxicol. Oncol. 1996;15:251–253. - PubMed
-
- Siddiqui M.S., Kayani N., Sulaiman S., Hussainy A.S., Shah S.H., Muzaffar S. Breast carcinoma in Pakistani females: A morphological study of 572 breast specimens. J. Pak. Med. Assoc. 2000;50:174–177. - PubMed
LinkOut - more resources
Full Text Sources